Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.

Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.

Although growth hormone (GH) replacement therapy is increasingly utilized in the management of adult hypopituitary patients, optimum dosing schedules are poorly defined. The use of weight-based or surface area-based dosing may result in overtreatment, and individual variation in susceptibility on th...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	Drake, WM, Coyte, D, Camacho-Hübner, C, Jivanji, N, Kaltsas, G, Wood, D, Trainer, P, Grossman, AB, Besser, G, Monson, J
פורמט:	Journal article
שפה:	English
יצא לאור:	1998

פריטים דומים

Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
מאת: Florakis, D, et al.
יצא לאור: (2000)

Comments on 'Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two-year study' by Florakis et al (2000) - Reply
מאת: Monson, J, et al.
יצא לאור: (2001)

Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy.
מאת: Frajese, G, et al.
יצא לאור: (2001)

Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours.
מאת: Chung, T, et al.
יצא לאור: (2008)

Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients.
מאת: Agha, A, et al.
יצא לאור: (2007)

Growth hormone replacement does not increase serum prostate-specific antigen in hypopituitary men over 50 years.
מאת: le Roux, C, et al.
יצא לאור: (2002)

Role of fasting plasma glucose, glycated haemoglobin and homeostatic model assessment in the detection of glucose intolerance in adult hypopituitary patients during growth hormone replacement therapy.
מאת: Colson, A, et al.
יצא לאור: (2008)

Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.
מאת: Chung, T, et al.
יצא לאור: (2005)

Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity.
מאת: Kaltsas, G, et al.
יצא לאור: (2001)

Insulin-like growth factor-I and- II in combination inhibit the release of growth hormone-releasing hormone from the rat hypothalamus in vitro.
מאת: Korbonits, M, et al.
יצא לאור: (1996)

The effect of growth hormone (GH) replacement therapy on sympathetic nerve hyperactivity in hypopituitary adults: a double-blind, placebo-controlled, crossover, short-term trial followed by long-term open GH replacement in hypopituitary adults.
מאת: Sverrisdóttir, Y, et al.
יצא לאור: (2003)

Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration.
מאת: Jenkins, P, et al.
יצא לאור: (2000)

Growth hormone deficiency and replacement in patients with treated Cushing's Disease, prolactinomas and non-functioning pituitary adenomas: effects on body composition, glucose metabolism, lipid status and bone mineral density.
מאת: Colson, A, et al.
יצא לאור: (2006)

The modulation of platelet function by growth hormone in growth hormone deficient Hypopituitary patients
מאת: Irene K Oglesby, et al.
יצא לאור: (2023-09-01)

The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
מאת: Korbonits, M, et al.
יצא לאור: (1999)

Hexarelin as a test of pituitary reserve in patients with pituitary disease.
מאת: Korbonits, M, et al.
יצא לאור: (1999)

Pyridostigmine partially reverses dexamethasone-induced inhibition of the growth hormone response to growth hormone-releasing hormone.
מאת: Trainer, P, et al.
יצא לאור: (1992)

Authors' response: The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women
מאת: Kaltsas, G, et al.
יצא לאור: (2003)

The prevalence and characteristic features of cyclicity and variability in Cushing's disease.
מאת: Alexandraki, K, et al.
יצא לאור: (2009)

How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
מאת: Kaltsas, G, et al.
יצא לאור: (2000)

Classic cardiovascular risk factors improve in very elderly hypopituitary patients treated on standard hormone replacement in long term follow- up
מאת: Isabella Naves Rosa, et al.
יצא לאור: (2021-03-01)

CT appearance of the adrenal glands in adrenocorticotrophic hormone-dependent Cushing's syndrome.
מאת: Sohaib, SA, et al.
יצא לאור: (1999)

Complications of inferior petrosel sinus sampling.
מאת: Kaltsas, G, et al.
יצא לאור: (2000)

Circulating Levels of Irisin in Hypopituitary and Normal Subjects.
מאת: Lara Pena-Bello, et al.
יצא לאור: (2016-01-01)

Benzodiazepines attenuate the pituitary-adrenal responses to corticotrophin-releasing hormone in healthy volunteers, but not in patients with Cushing's syndrome.
מאת: Korbonits, M, et al.
יצא לאור: (1995)

Prevalence and risk factors of the metabolic syndrome in young adults with childhood-onset hypopituitary growth hormone deficiency
מאת: Han Hyuk Lim, et al.
יצא לאור: (2010-10-01)

Gamma knife radiosurgery: a safe and effective salvage treatment for pituitary tumours not controlled despite conventional radiotherapy.
מאת: Swords, F, et al.
יצא לאור: (2009)

The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumors.
מאת: Kaltsas, G, et al.
יצא לאור: (1998)

Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
מאת: Isidori, A, et al.
יצא לאור: (2003)

Male-female differences in 6-sulfatoxymelatonin excretion in hypopituitary patients
מאת: Hugo L. Fideleff, et al.
יצא לאור: (2016-02-01)

Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
מאת: Newell-Price, J, et al.
יצא לאור: (2002)

NITRIC-OXIDE AS A NOVEL REGULATOR OF NEUROENDOCRINE FUNCTION - CONTROL OF CORTICOTROPIN-RELEASING HORMONE-41 RELEASE FROM THE RAT HYPOTHALAMUS INVITRO
מאת: Costa, A, et al.
יצא לאור: (1992)

Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
מאת: Korbonits, M, et al.
יצא לאור: (1998)

A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia.
מאת: Miraki-Moud, F, et al.
יצא לאור: (2005)

A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome.
מאת: Kaltsas, G, et al.
יצא לאור: (1999)

Initial response of young people with thyrotoxicosis to block and replace or dose titration thionamide
מאת: Claire L Wood, et al.
יצא לאור: (2023-01-01)

Clinical, radiological and pathological features of patients with Rathke's cleft cysts: tumors that may recur.
מאת: Mukherjee, J, et al.
יצא לאור: (1997)

BENZODIAZEPINES ATTENUATE THE SERUM CORTISOL RESPONSE TO CORTICOTROPIN-RELEASING HORMONE (CRH) IN HEALTHY-VOLUNTEERS
מאת: Trainer, P, et al.
יצא לאור: (1992)

No clear evidence for an association between GH replacement and relapse of intracranial germ cell tumours: single centre and KIMS experience.
מאת: Chung, T, et al.
יצא לאור: (2010)

Nitric oxide modulates the release of corticotropin-releasing hormone from the rat hypothalamus in vitro.
מאת: Costa, A, et al.
יצא לאור: (1993)